Drugs & medical class action settlements
Class action settlements involving drugs, supplements, medical devices, and health products.
Drugs & medical settlements by the numbers
A settlement fund is the total a defendant agreed to pay, not what any one claimant receives — most funds are divided among everyone who files. Settlements are negotiated agreements, and defendants typically deny wrongdoing rather than being found liable.
Get new claim opportunities by email
Free alerts for new settlements and deadlines. Unsubscribe anytime.
Accepting claims now
Drugs & medical cases in litigation
Filed and being fought in court. These are allegations — there is no settlement, no claim form and no payout yet.
Conner v. Liberty Healthcare Corporation
A proposed class action against Liberty Healthcare Corporation involving a dispute over personal property or assets. Based on the nature of suit and defendant type, this appears to concern alleged wrongful conduct by a healthcare provider affecting patients or account holders, though specific details of the allegations are not available from the docket information provided.
Q.M. v. Liberty Healthcare Corporation Class Action
A proposed class action has been filed against Liberty Healthcare Corporation by Q.M. The complaint is docketed under 'Other Statutes' but the specific factual allegations are not disclosed in the docket metadata provided. Based on the defendant's apparent healthcare operations, the case likely involves claims relevant to patients or healthcare consumers, though the precise nature of the allegations cannot be determined from the caption and filing information alone.
Fazio v. American Addiction Centers Class Action
This is a proposed class action against American Addiction Centers, Inc., a company that operates addiction treatment facilities. While specific allegations are not available from the provided docket information, the case likely involves claims by patients or consumers regarding treatment practices, facility operations, billing practices, or other matters related to addiction treatment services.
Humphreys v. Amgen Inc.
This is a proposed class action against Amgen Inc. concerning alleged issues related to personal property or products, likely involving a pharmaceutical or medical product based on Amgen's business. The complaint was recently filed but specific allegations are not available from the docket metadata provided.
Williams v. Lemontree Healthcare Services
A proposed class action against Lemontree Healthcare Services LLC, apparently concerning healthcare services or treatment provided to patients. The specific allegations cannot be determined from the limited caption information available, but the case appears to involve potential claims on behalf of healthcare consumers or patients.
Petersen v. Exact Sciences Corporation
A proposed class action against Exact Sciences Corporation filed by Nicole Petersen. The nature of suit is listed as "Other" personal injury, but based on the defendant's identity as a major cancer-screening company, this likely concerns allegations related to medical testing, screening products, or related health claims. Without access to the complaint itself, the specific allegations cannot be determined from the docket entry alone.
B.W. v. Invitae Corporation
This is a proposed class action against Invitae Corporation, a genetic testing and healthcare company. The case was removed from Illinois state court, but the specific allegations cannot be determined from the docket entry provided. Based on Invitae's business model, the claims likely involve issues related to genetic testing services, medical diagnostics, or related consumer health services, though the precise nature of the allegations remains unclear from the removal notice alone.
Coburn v. Johnson & Johnson Talc Product Liability Class Action
A proposed class action alleges personal injury and product liability claims related to talc products apparently manufactured or distributed by Johnson & Johnson and related defendants. The case, originally filed in 2024 and refiled in 2026, names individual plaintiffs and seeks to represent a class of consumers injured by the talc-based products at issue.
Johnson v. Abbott Laboratories
A proposed class action has been filed against Abbott Laboratories in federal court in Illinois. Without access to the complaint details, the specific allegations cannot be determined from the docket information available, but the case likely involves a consumer or patient claim related to Abbott's medical products or pharmaceuticals.
Schnitzer v. Albany Med Health System Class Action
This proposed class action against Albany Med Health System involves allegations arising from the defendant's healthcare operations or practices. While the specific claims are not detailed in the available docket information, the case appears to concern matters that could affect patients or healthcare consumers served by the health system.
Delong v. Glucobit Inc.
A proposed class action filed against Glucobit Inc. under a contract theory of liability. The case involves allegations related to either the sale or performance of Glucobit's products or services, though specific details are not yet available in the docket entries.
Closed to new claims
Past the filing deadline — kept so you can look up what a case was about and what it paid.
Metformin Marketing and Sales Practices Settlement
The defendants falsely advertised their generic metformin drugs as equivalent to Glucophage and Glucophage XR, but the drugs were contaminated with NDMA and did not meet FDA standards. Consumers and businesses paid for drugs they would not have purchased had they known the truth. The defendants deny wrongdoing.
Tracleer Litigation Settlement
The defendants allegedly unlawfully delayed the entry of generic formulations of bosentan into the market, causing third-party payors to pay more for brand Tracleer and bosentan than they should have. Defendants deny wrongdoing and there has been no court determination that the allegations were proven or caused harm.
QVAR Antitrust Settlement
Teva allegedly violated antitrust laws by improperly listing patents in the FDA's Orange Book and engaging in product hopping to delay generic competition for QVAR and QVAR Redihaler inhalers, causing consumers and third-party payors to overpay for the brand-name drug. Teva denies all allegations and maintains it did nothing wrong.
Natera Prenatal Testing Settlement
Natera allegedly violated certain laws in connection with sales of its noninvasive prenatal screening tests under the names Panorama or Vasistera. Natera denies any wrongdoing and denies violating any law. The parties agreed to settle to avoid the uncertainties and expenses of continued litigation.
Paid Up to the amount paid out of pocket for the test
Whitman Hospital & Medical Center Data Breach Settlement
Whitman Hospital & Medical Center experienced a data breach between December 26, 2024 and February 28, 2025 that compromised patients' private information. The hospital has agreed to pay $500,000 to settle claims arising from this incident.
Paid $60–$5,000
Sartan Medications Settlement - Valsartan, Losartan, and Irbesartan
Multiple pharmaceutical manufacturers sold blood pressure medications (Valsartan, Losartan, and Irbesartan) that allegedly contained contamination with probable human carcinogens including N-nitrosodimethylamine (NDMA), nitrosamine impurities, and NMBA. The defendants have denied wrongdoing and denied that the contamination amounts were carcinogenic.
Anthem Residential Treatment Coverage Denial Settlement
Anthem denied claims for residential treatment coverage for mental health conditions and substance use disorders, allegedly using medical necessity criteria that were more restrictive than accepted standards of care and the terms of health benefit plans. Anthem denies the allegations but settled to avoid litigation costs and uncertainty.
Paid Amount depends on how many class members submit claims and will likely not be full reimbursement of out-of-pocket expenses. Class members who do not submit claims receive a nominal payment.
Sutter Anesthesia Billing Lawsuit Settlement
Sutter Health allegedly engaged in fraudulent, unlawful, and unfair billing practices by submitting and receiving payment on bills for anesthesia services that were not rendered, were double-billed, or were misleadingly described. This caused self-funded payers to pay more for anesthesia services than they should have. Sutter Health denies all allegations and maintains that its practices complied with applicable laws.
MSU Counseling & Mental Health Services Fund
Former doctor Larry Nassar, who provided treatment at Michigan State University health clinics and to student-athletes, engaged in abuse against survivors. MSU established this fund to reimburse survivors and their family members for eligible out-of-pocket mental health treatment expenses.
Paid Reimbursement of eligible out-of-pocket expenses for mental health treatment